The global life sciences industry is confronted with a host of challenges, including the healthcare crisis in many countries (especially the US), a declining patents regime, growing competition from generic producers, greater regulatory scrutiny, pricing pressures, changing demographics and the emergence of new untapped markets.

Estimates are that the global pharmaceuticals, biotechnology and life sciences industry generated revenues of over $1.1 trillion in 2011, with pharmaceuticals accounting for nearly $800 billion and biotechnology about $300 billion. A rapidly ageing population in the developed world and healthcare reforms that are bringing in millions of uninsured citizens in the US into the insurance net are expected to boost demand for pharmaceuticals and life science products.

Why Iris
We have a select clientele from across the pharmaceuticals, biologics, immunology, medical device, biopharma, healthcare equipment, hospital software, and other life sciences companies. Our solutions are wide-ranging, from serialization to aid in packaging, anti-diversion measures at the packaging lines and distribution system, and IT upgrades to meet the changing regulatory environment, to turnkey IT projects and staffing solutions.

Our solutions cover several functional areas including:
  • Data aggregation at packaging lines
  • Shop floor WiP management
  • Asset tracking & management
  • Packaging execution system
  • Data warehousing & business intelligence software
  • Compliance & regulatory applications
  • Payment gateways and portal development
  • Product engineering & development activities
  • Data warehousing & business intelligence software
  • Health planning/analysis applications
  • HIPAA compliance software & EDI integration